Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Simon Spichak, MSc
Alzheimer’s Drug Leqembi Approved in Canada
Cassava Fraud Case Dismissed, Closing a Chapter in Alzheimer’s Drug Saga
NIH Alzheimer’s Research Funding Is Back — for 49% Fewer Projects
Cleaner Air, Healthier Brains: Study Links Air Pollution to Alzheimer’s Plaques and Tangles
Has Fraud Really Hijacked Alzheimer’s Science? Book Review: Charles Piller’s ‘Doctored’
STUDY: Even Small Amounts of Alcohol Seem to Boost Dementia Risk
Your Cat’s Brain Could Hold Secrets to Alzheimer’s
Could Alzheimer’s Drugs Work Better in Pairs? A New Approach for ‘Mabs’
Gene Therapy ‘First’: Huntington’s Disease Treated in Early Trial
Australia Drug Regulators Approve Leqembi for Alzheimer’s
Bridging the Diversity Gap: Why Alzheimer’s Research in Africa Matters
How a Brainwave Test Can Help Foretell Alzheimer’s in Just 3 Minutes
Lewy Body Dementia Treatment: What Helps Now, and What’s in Clinical Trials
Inside Look: How Doctors Diagnose Lewy Body Dementia
Menopause, Hormone Therapy, and Alzheimer’s: Why HRT Timing Matters
Previous
5
6
7
Next
Page load link
Go to Top